This inventor holds 1 USPTO granted patent. Top assignee: American Cyanamid Company. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: The Innovative Contributions of Martin P. Kuntsmann
Introduction
Martin P. Kuntsmann is a notable inventor based in Pearl River, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of calicheamicin derivatives. His work has implications for drug delivery systems and cancer treatment.
Latest Patents
Martin P. Kuntsmann holds a patent for a method for the preparation of substantially monomeric calicheamicin. This method provides a way to prepare monomeric calicheamicin derivative/carrier conjugates with higher drug loading and yield, while also decreasing aggregation. The process involves incubating a calicheamicin derivative and a proteinaceous carrier in a phosphate buffered solution, along with a cosolvent such as propylene glycol and an additive comprising a carboxylic acid. The incubation occurs at a controlled temperature and pH for a specified duration, resulting in the recovery of the desired conjugates.
Career Highlights
Throughout his career, Kuntsmann has been associated with the American Cyanamid Company, where he has contributed to various innovative projects. His expertise in pharmaceutical formulations has positioned him as a valuable asset in the industry.
Collaborations
Martin P. Kuntsmann has worked alongside notable colleagues such as Irwin J. Hollander and Philip R. Hamann. Their collaborative efforts have further advanced the research and development of effective drug delivery systems.
Conclusion
Martin P. Kuntsmann's innovative work in the preparation of calicheamicin derivatives showcases his commitment to advancing pharmaceutical science. His contributions have the potential to enhance drug delivery methods and improve patient outcomes.